Indegene IPO shares are trading with a GMP of Rs 290 in the unlisted market, and considering the upper price band of Rs 490, the stock is expected to list with a premium of over 60%. Ahead of the issue opening, the company raised nearly Rs 549 crore from anchor investors.
Market in consolidation mode; triggers needed, says Sunil Subramaniam
Indian pharma stocks are rebounding, driven by domestic investors after a period of Foreign Institutional Investor (FII) selling pressure. Uncertainty surrounding potential US tariffs, fueled